Screener
Krystal Biotech, Inc. KRYS Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except per share data) | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Cost of goods sold | 6,323 | 5,028 |
| Research and development | 15,331 | 14,256 |
| Selling, general and administrative | 41,014 | 32,647 |
| Total operating expenses | 62,668 | 51,931 |
| Income from operations | 53,689 | 36,252 |
| Other income | ||
| Interest and other income, net | 7,753 | 7,345 |
| Income before income taxes | 61,442 | 43,597 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s other operating expenses?
- Krystal Biotech, Inc. (KRYS) reported other operating expenses of $62.67M in Q1 2026.
- How has Krystal Biotech, Inc.'s other operating expenses changed year-over-year?
- Krystal Biotech, Inc.'s other operating expenses increased by 20.7% year-over-year, from $51.93M to $62.67M.
- What is the long-term trend for Krystal Biotech, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s other operating expenses has grown at a 35.2% compound annual growth rate (CAGR), from $68.27M to $227.93M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Krystal Biotech, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude